|
MSN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.07740000005108E-06 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.502000E-02 |
| Stage1-vs-Stage3 |
5.968800E-01 |
| Stage1-vs-Stage4 |
6.187600E-02 |
| Stage2-vs-Stage3 |
2.222600E-01 |
| Stage2-vs-Stage4 |
9.244200E-03 |
| Stage3-vs-Stage4 |
3.320200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.04890000002445E-06 |
| Normal-vs-Asian |
7.28295201923856E-12 |
| Caucasian-vs-AfricanAmerican |
6.808000E-01 |
| Caucasian-vs-Asian |
1.353830E-01 |
| AfricanAmerican-vs-Asian |
5.764800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.764800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6269208202857E-12 |
| Normal-vs-Age(81-100Yrs) |
4.566400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.128200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.349620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.664400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.801000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.290400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.463980E-01 |
| Classical-VS-Follicular |
1.68020042323747E-11 |
| Classical-VS-Other |
7.565600E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.0556000518136E-09 |
| Tall-VS-Other |
6.783800E-02 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
6.501600E-01 |
| Follicular-VS-Normal |
1.83789999996797E-06 |
| Other-VS-Normal |
1.192380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
1.79889436680014E-12 |
| N0-vs-N1 |
1.826180E-02 |
|
|
